COPSAC COPSAC COPSAC COPSAC
  • About COPSAC
    • About
    • Organization Diagram
    • Board of Directors
    • Research team
    • Location
    • Funding
    • Logo
    • Open positions
  • COPSAC cohorts
    • COPSAC2000 cohort
    • COPSAC2010 cohort
    • COPSACSEVERE cohort
    • COPSACACUTE cohort
    • Methods
    • Data overview
      • COPSAC2000 Clinic
      • COPSAC2000 Exposures
      • COPSAC2000 Omics
      • COPSAC2000 Biobank
      • COPSAC2010 Clinic
      • COPSAC2010 Exposures
      • COPSAC2010 Omics
      • COPSAC2010 Biobank
  • Dissemination
    • Theses
    • Literature for parents
  • Research Projects
    • RestoreGut
    • COPSYCH Research Alliance
    • HEDIMED Consortium
    • EDIAQI Consortium
    • EAGLE Consortium
    • EarlyVir
  • Strategy
  • ‌

2014 Marie Kragh, MSc PhD

  • 2015 Ann-Marie Malby Schoos, MD PhD
    • Thesis_2015_Ann-Marie_Schoos
  • 2014 Marie Kragh, MSc PhD
    • Thesis_2014_Marie-Kragh.pdf
  • 2014 Eskil Kreiner-Møller, MD PhD
    • Thesis_2014_Eskil-Kreiner-Moller
  • 2014 Nadja Hawwa Vissing, MD PhD
    • Thesis_2014_Nadja-Vissing
  • 2014 Anna Hammerich Thysen, Msc PhD
    • Thesis_2014_Anna-Thysen
  • 2013 Charlotte Giwercman Carson MD, PhD
    • Thesis_2013_Charlotte-Giwercman
  • 2013 Anne Louise Bischoff MD, PhD
    • Thesis_2013_Anne-Bischoff
  • 2012 Louise Pedersen, MD, PhD
    • Thesis_2012_Louise-Pedersen
  • 2012 Jakob Stokholm, MD, PhD
    • Thesis_2012_Jakob-Stokholm
  • 2012 Nilofar Følsgaard, MD, PhD
    • Thesis_2012_Nilo-Foelsgaard
  • 2011 Martin Brasholt, MD, PhD
    • Thesis_2011_Martin-Brasholt
  • 2011 Bo Chawes, MD, PhD
    • Thesis_2011_Bo-Chawes
  • 2010 Klaus Bønnelykke, MD, PhD
    • Thesis_2010_Klaus-Bonnelykke
  • 2010 Porntiva Poorisrisak, MD, PhD
    • Thesis_2010_Porntiva-Poorisrisak
  • 2009 Mette N Hermansen, MD, PhD
    • Thesis_2009_Mette-Hermansen
  • 2006 Liselotte B Halkjær, MD, PhD
    • Thesis_2006_Liselotte-Halkjær
  • 2006 Birgitte Boysen Kjær, MD, PhD
  • 2004 Lotte Loland, MD, PhD
    • Thesis_2004_Lotte-Loland
  • 2002 Frederik F Buchvald, MD, PhD
    • Thesis_2002_Frederik-Buchvald
  • 1999 Marianne Stubbe Østergaard, MD, PhD
  • 1993 Jytte Fogh, MD, PhD
  • 2017 Elín Bjarnadóttir, MD PhD
  • 2017 Helene Wolsk, MD
  • 2017 Tine Marie Pedersen, MD
  • 2017 Astrid Sevelsted, MSc
  • 2017 Rebecca Kofod Vinding, MD
  • 2019 Lambang Arianto, MD
  • 2018 Henrik Hallas, MD
  • 2018 Jonathan Thorsen, MD
  • 2018 Nadia Rahman Fink, MD
  • 2019 Christian Carlsson, MD
  • 2019 Christian Carlsson, MD
  • 2019 Ni Wang, MD
  • 2021 Sarah Nørgaard – MSc
  • 2020 Asja Kunøe – MD
  • 2021 Nicklas Brustad – MD
  • 2021 Anders Eliasen – MSc
  • 2021 Lærke Sass – MD
  • 2022 Pia Nørrisgaard – MSc
  • 2022 Emil Christensen – MD
  • 2023 Rikke Sunde – MD
  • 2023 Julie Kyvsgaard – MD
  • 2024 Yang Luo – MSc
  • 2024 Julie Rosenberg – MD
  • 2024 Christina Poulsen – MSc
  • 2024 Parisa Mohammadzadeh – MD
  • 2024 Signe Jensen – MD
  • 2024 David Horner – MD
  • 2025 Liang Chen
  • 2025 Sarah Brandt
  • 2025 Kasper Rasmussen
  • 2025 Mathias Melgaard
Home Home Dissemination Theses 2014 Marie Kragh, MSc PhD

Environmental Factors Influencing Immunity and the Development of Diseases Later in Life

By Marie Kragh MSc, PhD

Summary

Chariman: Ole Lund

Opponent: Dennis Sandris Nielsen

Opponent: Thomas Eiwegger

(PDF)

The prevalence of chronic inflammatory diseases in children, including childhood asthma, has increased during the past decades resulting in reduced quality of life for the implicated child and family, and an increased socioeconomic burden. Complex interactions between genetic factors (genetic predisposition) and the exposed environment, beginning as early as in perinatal life, are recognized causes of chronic inflammatory diseases.

This PhD thesis focuses on two potential environmental risk exposures for development of childhood asthma, namely maternal parity, and postpartum bacterial colonisation of the upper respiratory tract. The aim with this thesis was to investigate how maternal parity history affected neonatal immunity; and whether hereditary and environmental risk factors affected bacterial diversity in the upper respiratory tract of asymptomatic neonates. The study is based on clinical material from the birth cohorts of Copenhagen Prospective Studies on Asthma in Childhood (COPSAC).

The first study in the PhD thesis assessed how purified cord blood T cells from newborns of primiparous versus multiparous mothers react upon polyclonal activation in vitro. These data showed a reduced anti-inflammatory T cell function in first-born children as the IL-10 secretion and CD25 expression on CD4+ helper T cells were diminished as opposed to second- or later-born children. The result suggested that in utero T cell programing is responsible for this finding, which could be one of the explanations for the well-known epidemiological observations of enhanced risk for development of immune-mediated diseases in first-born children.

The second study assessed the associations between bacterial diversity and genetic predisposition for atopy and environmental risk factors relevant to establishment of a microbiota in the upper airways of newborns. The study showed a high diversity of nasopharyngeal bacterial in asymptomatic 1-month old infants. Moreover, season of birth was found to associate to nasopharyngeal bacterial diversity, with a higher bacterial diversity as well as specific bacteria profiles representing Gram-negative alphaproteobacteria and Gram-positive Bacilli in the nasopharynx of summer-born children. The result suggested that early postnatal colonization of the upper airways may reflect surrounding air at birth. A focus on the aspect of seasonality in modelling the impact of early dynamic changes in airway communities in relation to later disease development should be included in future studies. Overall, these findings contribute to our understanding of how common environmental factors, such as maternal parity and season of birth are associated to the development of the newborn’s immune system and nasal microbiota. These environmental factors tend to be overlooked both in the study design, statistical analysis and reporting of scientific studies. This may result in misinterpretations and errors in our search for causes of childhood asthma and other chronic inflammatory diseases.


CONTACT

COPSAC
Copenhagen Prospective Studies on Asthma in Childhood
Copenhagen University Hospital, Herlev-Gentofte
phone +45 3867 7360
contact@copsac.com
COPSAC • Copenhagen University Hospital, Herlev-Gentofte • Denmark © 2023
  • About COPSAC
    • About
    • Organization Diagram
    • Board of Directors
    • Research team
    • Location
    • Funding
    • Logo
    • Open positions
  • COPSAC cohorts
    • COPSAC2000 cohort
    • COPSAC2010 cohort
    • COPSACSEVERE cohort
    • COPSACACUTE cohort
    • Methods
    • Data overview
      • COPSAC2000 Clinic
      • COPSAC2000 Exposures
      • COPSAC2000 Omics
      • COPSAC2000 Biobank
      • COPSAC2010 Clinic
      • COPSAC2010 Exposures
      • COPSAC2010 Omics
      • COPSAC2010 Biobank
  • Dissemination
    • Theses
    • Literature for parents
  • Research Projects
    • RestoreGut
    • COPSYCH Research Alliance
    • HEDIMED Consortium
    • EDIAQI Consortium
    • EAGLE Consortium
    • EarlyVir
  • Strategy
  • ‌
COPSAC